# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-16-725582
Filing Date
2016-09-29
Accepted
2016-09-29 15:30:04
Documents
7
Period of Report
2016-09-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | d278290d8k.htm | 8-K | 12005
2 | EX-99.1 | d278290dex991.htm | EX-99.1 | 24187
3 | EX-99.2 | d278290dex992.htm | EX-99.2 | 3915
4 | GRAPHIC | g278290ex99_2s1g1.jpg | GRAPHIC | 260354
5 | GRAPHIC | g278290ex99_2s2g1.jpg | GRAPHIC | 416900
6 | GRAPHIC | g278290ex99_2s3g1.jpg | GRAPHIC | 243796
7 | GRAPHIC | g278290ex99_2s4g1.jpg | GRAPHIC | 215150
| Complete submission text file | 0001193125-16-725582.txt |  | 1607000

Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-21898 | Film No.: 161909899
SIC: 2834 Pharmaceutical Preparations